Showing 201 - 220 results of 1,139 for search '"preclinical"', query time: 0.05s Refine Results
  1. 201

    Oral Health Knowledge, Attitudes and Behaviors in Dental and Oral Health Program Students: A Descriptive Cross-Sectional Study by Zeynep Taştan Eroğlu, Tuğçe Yıldız

    Published 2024-12-01
    “…The data were statistically analyzed with a significance level set at p<0.05.Results: This study involved 295 students: 151 preclinical dental, 76 clinical dental, 34 preclinical, and 34 clinical oral and dental health program students. …”
    Get full text
    Article
  2. 202

    Emerging Applications for Optically Enabled Intravital Microscopic Imaging in Radiobiology by Azusa Maeda, Iris Kulbatski, Ralph S. DaCosta

    Published 2015-09-01
    “…Radiation therapy is an effective cancer treatment used in over 50% of cancer patients. Preclinical research in radiobiology plays a major role in influencing the translation of radiotherapy-based treatment strategies into clinical practice. …”
    Get full text
    Article
  3. 203

    Protective effect of exercise on animals with sepsis: a systematic review of the existing literature by Na Yang, Nan Jiang, Chunming Shen, Ming Gao, Qian Tong, Jian Sun

    Published 2025-02-01
    “…Objectives To investigate the effects of exercise training on sepsis in preclinical studies and explore possible mechanisms to provide reliable preclinical evidence for the use of exercise training in sepsis. …”
    Get full text
    Article
  4. 204

    Interactions between Neutrophils, Th17 Cells, and Chemokines during the Initiation of Experimental Model of Multiple Sclerosis by Dagmara Weronika Wojkowska, Piotr Szpakowski, Dominika Ksiazek-Winiarek, Marcin Leszczynski, Andrzej Glabinski

    Published 2014-01-01
    “…Production of IL-17, IL-23, CCL20, and CXCL16 in the CNS was increased during both preclinical and acute EAE. Intracerebral delivery of CXCL1 stimulated the early accumulation of neutrophils in normal and preclinical EAE brains but reduced the migration of Th17 cells to the brain during the preclinical stage of EAE. …”
    Get full text
    Article
  5. 205
  6. 206
  7. 207
  8. 208
  9. 209

    Association between Probiotics and Modulation of Gut Microbial Community Composition in Colorectal Cancer Animal Models: A Systematic Review (2010–2021) by Shabnam Zeighamy Alamdary, Shahnaz Halimi, Akram Rezaei, Roghayeh Afifirad

    Published 2023-01-01
    “…The present systematic review results indicate that probiotics could modulate the gut microbial composition and immune regulation to combat/inhibit CRC in preclinical models. However, where the evidence is more limited, it is critical to transfer preclinical research into clinical data.…”
    Get full text
    Article
  10. 210
  11. 211

    Successfully Climbing the “STAIRs”: Surmounting Failed Translation of Experimental Ischemic Stroke Treatments by Michael P. Kahle, Gregory J. Bix

    Published 2012-01-01
    “…The Stroke Therapy Academic Industry Roundtable (STAIR) provided initial (in 1999) and updated (in 2009) recommendations with the goal of improving preclinical stroke therapy assessment and to increase the translational potential of experimental stroke treatments. …”
    Get full text
    Article
  12. 212
  13. 213

    Syrian hamsters (Mesocricetus auratus) as an upper respiratory tract model for respiratory syncytial virus infection by Sophie M. Kolbe, Kate Guilfoyle, Wencke Reineking, Geert van Amerongen, Guido van der Net, Sandra Lockow, Wolfgang Baumgärtner, Martin Ludlow, Albert D.M.E Osterhaus

    Published 2025-01-01
    “…Vaccines have recently been approved for use in adults and although further efforts to develop suitable interventions for children are ongoing, there are limited animal models for RSV infection. For preclinical efficacy testing of prophylactic and therapeutic treatments cotton rat and ferret models can be used. …”
    Get full text
    Article
  14. 214
  15. 215
  16. 216
  17. 217

    Potential of Peroxisome Proliferator-Activated Receptor Gamma Antagonist Compounds as Therapeutic Agents for a Wide Range of Cancer Types by Jack D. Burton, David M. Goldenberg, Rosalyn D. Blumenthal

    Published 2008-01-01
    “…Since PPARγ is expressed by many hematopoietic, mesodermal and epithelial cancers, agonist drugs were tested and shown to have both preclinical and clinical anticancer activities. While preclinical activity has been observed in many cancer types, clinical activity has been observed only in pilot and phase II trials in liposarcoma and prostate cancer. …”
    Get full text
    Article
  18. 218
  19. 219
  20. 220